Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Merville

Showing results (51-60 of 130) with videos related to

Pageof 13
Sort By:
Antiviral Research|February 19, 2013
Novel DNA polymerase mutations conferring cytomegalovirus resistance: input of BAC-recombinant phenotyping and 3D modelSébastien Hantz, Sébastien Cotin, Eva Borst, et al.
BMC Nephrology|April 7, 2017
Cost-effectiveness of home telemonitoring in chronic kidney disease patients at different stages by a pragmatic randomized controlled trial (eNephro): rationale and study designNathalie Thilly, Jacques Chanliau, Luc Frimat, et al.
Urology|October 30, 2009
Therapeutic management of de novo urological malignancy in renal transplant recipients: the experience of the French Department of Urology and Kidney Transplantation from BordeauxHicham Elkentaoui, Grégoire Robert, Gilles Pasticier, et al.
Transplantation|June 24, 2016
Reassessment of T Lymphocytes Crossmatches Results Prediction With Luminex Class I Single Antigen Flow Beads AssayJonathan Visentin, Thomas Bachelet, Cécile Borg, et al.
Transplantation|November 17, 2015
Evolution and Determinants of Health-Related Quality-of-Life in Kidney Transplant Patients Over the First 3 Years After TransplantationClaire Villeneuve, Marie-Laure Laroche, Marie Essig, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 24, 2016
Contribution of next generation sequencing to early detection of cytomegalovirus UL97 emerging mutants and viral subpopulations analysis in kidney transplant recipientsIsabelle Garrigue, Rémi Moulinas, Patricia Recordon-Pinson, et al.
Journal of Transplantation|September 19, 2012
Evaluation of protocol biopsy utility 12 months after renal transplantation: a multicenter observational analysisBruno Moulin, Pierre Merville, Karine Renaudin, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 15, 2026
Spiroplasma infection complicated by macrophage activation syndrome and fulminant hepatitis in a kidney transplanted patientImane Farhat, Hannah Kaminski, Pierre Louis Woerther, et al.
Journal of the American Society of Nephrology : JASN|April 19, 2014
Cytomegalovirus-responsive γδ T cells: novel effector cells in antibody-mediated kidney allograft microcirculation lesionsThomas Bachelet, Lionel Couzi, Vincent Pitard, et al.
Clinical Transplantation|February 17, 2015
Clinical impact of preformed donor-specific denatured class I HLA antibodies after kidney transplantationJonathan Visentin, Mélanie Marroc, Gwendaline Guidicelli, et al.
Pageof 13

Showing results (51-60 of 130) with videos related to

Sort By:
Pageof 13
Antiviral Research|February 19, 2013
Novel DNA polymerase mutations conferring cytomegalovirus resistance: input of BAC-recombinant phenotyping and 3D modelSébastien Hantz, Sébastien Cotin, Eva Borst, et al.
BMC Nephrology|April 7, 2017
Cost-effectiveness of home telemonitoring in chronic kidney disease patients at different stages by a pragmatic randomized controlled trial (eNephro): rationale and study designNathalie Thilly, Jacques Chanliau, Luc Frimat, et al.
Urology|October 30, 2009
Therapeutic management of de novo urological malignancy in renal transplant recipients: the experience of the French Department of Urology and Kidney Transplantation from BordeauxHicham Elkentaoui, Grégoire Robert, Gilles Pasticier, et al.
Transplantation|June 24, 2016
Reassessment of T Lymphocytes Crossmatches Results Prediction With Luminex Class I Single Antigen Flow Beads AssayJonathan Visentin, Thomas Bachelet, Cécile Borg, et al.
Transplantation|November 17, 2015
Evolution and Determinants of Health-Related Quality-of-Life in Kidney Transplant Patients Over the First 3 Years After TransplantationClaire Villeneuve, Marie-Laure Laroche, Marie Essig, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 24, 2016
Contribution of next generation sequencing to early detection of cytomegalovirus UL97 emerging mutants and viral subpopulations analysis in kidney transplant recipientsIsabelle Garrigue, Rémi Moulinas, Patricia Recordon-Pinson, et al.
Journal of Transplantation|September 19, 2012
Evaluation of protocol biopsy utility 12 months after renal transplantation: a multicenter observational analysisBruno Moulin, Pierre Merville, Karine Renaudin, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 15, 2026
Spiroplasma infection complicated by macrophage activation syndrome and fulminant hepatitis in a kidney transplanted patientImane Farhat, Hannah Kaminski, Pierre Louis Woerther, et al.
Journal of the American Society of Nephrology : JASN|April 19, 2014
Cytomegalovirus-responsive γδ T cells: novel effector cells in antibody-mediated kidney allograft microcirculation lesionsThomas Bachelet, Lionel Couzi, Vincent Pitard, et al.
Clinical Transplantation|February 17, 2015
Clinical impact of preformed donor-specific denatured class I HLA antibodies after kidney transplantationJonathan Visentin, Mélanie Marroc, Gwendaline Guidicelli, et al.
Pageof 13